+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Collplant Biotechnologies Ltd (CLGN) - Product Pipeline Analysis, 2020 Update

  • ID: 5240174
  • Company Profile
  • January 2021
  • 38 pages
  • GlobalData
  • CollPlant Ltd

FEATURED COMPANIES

  • AGAM Biological Products
  • Regentis Biomaterials Ltd
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Collplant Biotechnologies Ltd (CollPlant) is a regenerative medicine company that carries out the development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant’s wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant provides tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company also provides a surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Ness Ziona, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Collplant Biotechnologies Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AGAM Biological Products
  • Regentis Biomaterials Ltd
Collplant Biotechnologies Ltd Company Overview
  • Collplant Biotechnologies Ltd Company Snapshot
  • Collplant Biotechnologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Collplant Biotechnologies Ltd - Pipeline Analysis Overview
  • Collplant Biotechnologies Ltd - Key Facts
  • Collplant Biotechnologies Ltd - Major Products and Services
  • Collplant Biotechnologies Ltd Pipeline Products by Development Stage
Collplant Biotechnologies Ltd Pipeline Products Overview
  • 3D-Breast Implant
  • 3D-Breast Implant Product Overview
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion Product Overview
  • Dermal Filler
  • Dermal Filler Product Overview
  • Vergenix STR
  • Vergenix STR Product Overview
  • Vergenix STR - Anterior Cruciate Ligament
  • Vergenix STR - Anterior Cruciate Ligament Product Overview
  • Vergenix STR - Rotator Cuff Repair
  • Vergenix STR - Rotator Cuff Repair Product Overview
  • Vergenix SW
  • Vergenix SW Product Overview
  • Vergenix TRA
  • Vergenix TRA Product Overview
  • VergenixBVF
  • VergenixBVF Product Overview
  • VergenixDMR
  • VergenixDMR Product Overview
  • VergenixHVR
  • VergenixHVR Product Overview
  • VergenixPBR
  • VergenixPBR Product Overview
Collplant Biotechnologies Ltd - Key Competitors

Collplant Biotechnologies Ltd - Key Employees

Collplant Biotechnologies Ltd - Locations and Subsidiaries
  • Head Office
Recent Developments
  • Collplant Biotechnologies Ltd, Recent Developments
  • Nov 10, 2020: CollPlant announces early development program of antiviral agent for potential treatment of COVID-19 patients
  • Sep 16, 2020: CollPlant Biotechnologies presents on the use of novel, plant-derived, recombinant human collagen for anti-aging therapies at the Science of Aging Virtual Symposium 2020
  • Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement
  • Feb 10, 2020: CollPlant announces appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
  • Jan 06, 2020: CollPlant partners in the Advanced Regenerative Manufacturing Institute
  • Dec 19, 2019: CollPlant publishes letter to Shareholders
  • Nov 29, 2019: CollPlant reports third quarter 2019 financial results and provides business update
  • Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication's Industry Relations Committee
  • Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
  • Sep 05, 2019: CollPlant Biotechnologies to present at the 21st Annual Rodman & Renshaw Global Investment Conference
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Collplant Biotechnologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Collplant Biotechnologies Ltd Pipeline Products by Equipment Type
  • Collplant Biotechnologies Ltd Pipeline Products by Indication
  • Collplant Biotechnologies Ltd, Key Facts
  • Collplant Biotechnologies Ltd, Major Products and Services
  • Collplant Biotechnologies Ltd Number of Pipeline Products by Development Stage
  • Collplant Biotechnologies Ltd Pipeline Products Summary by Development Stage
  • 3D-Breast Implant - Product Status
  • 3D-Breast Implant - Product Description
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Status
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Description
  • Dermal Filler - Product Status
  • Dermal Filler - Product Description
  • Vergenix STR - Product Status
  • Vergenix STR - Product Description
  • Vergenix STR - Anterior Cruciate Ligament - Product Status
  • Vergenix STR - Anterior Cruciate Ligament - Product Description
  • Vergenix STR - Rotator Cuff Repair - Product Status
  • Vergenix STR - Rotator Cuff Repair - Product Description
  • Vergenix SW - Product Status
  • Vergenix SW - Product Description
  • Vergenix TRA - Product Status
  • Vergenix TRA - Product Description
  • VergenixBVF - Product Status
  • VergenixBVF - Product Description
  • VergenixDMR - Product Status
  • VergenixDMR - Product Description
  • VergenixHVR - Product Status
  • VergenixHVR - Product Description
  • VergenixPBR - Product Status
  • VergenixPBR - Product Description
  • Collplant Biotechnologies Ltd, Key Employees
  • Glossary
List of Figures
  • Collplant Biotechnologies Ltd Pipeline Products by Equipment Type
  • Collplant Biotechnologies Ltd Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Regentis Biomaterials Ltd
  • Meytav Technological Incubator
  • AGAM Biological Products
Note: Product cover images may vary from those shown
Adroll
adroll